Parsyl utilizes its commercial technology to solve major global health challenges.
Vaccines require strict temperature control to remain potent and effective. Unreliable transportation and storage networks in resource-limited settings make it difficult to maintain necessary conditions, and it is difficult to understand if, when and where vaccines may have gone bad. This uncertainty threatens to undermine the progress made by global vaccination efforts and increases the risk of future epidemics of vaccine-preventable diseases.
Freeze-sensitive vaccines procured
through UNICEF in 2015 totaled
of vaccines in lower income countries are exposed to temperatures below recommended ranges during storage
"...vaccines can travel thousands of miles across the world to reach remote communities in Africa and Asia, but if they become too hot or too cold during that very last mile all the effort is for naught. That’s why this partnership with Parsyl is so important, ensuring that countries are using the latest technology to keep these vaccines effective."Dr. Seth Berkley CEO of Gavi
Parsyl provides insights derived from granular data about environmental conditions experienced by sensitive health products during shipment and in storage - from the first mile to the last - to inform and encourage supply chain best practices.
Frontline health workers can easily understand the quality of vaccines prior to immunization, even in last mile locations.
Visibilty into causes and location of product degredation uncovers areas for focused improvement.
Global health partners can make data driven decisions about future shipment and storage methods to ensure vaccines remain safe and effective.
At Parsyl, we know the journey matters. We are proud to work with governments, international donor organizations and the private sector to strengthen global health supply chains and improve lives. We work with ministries of health to monitor country-wide health systems. We work with logistics providers to monitor multi-modal shipments. And we work with non-profits who believe that the innovations of private industry can improve health for all.
We are always looking for new partners who share our commitment to delivering high-quality vaccines and pharmaceuticals to underserved populations.
Gavi expects to immunize 300 million children between 2016 and 2020 and avert 5-6 million future deaths through its support for routine immunization programs and vaccination campaigns.